The Latest

This Week in HIV Research: Better Serving the Underserved

May 9, 2019: HIV care retention and viral suppression among transgender women; heating opioid use equipment to curb HIV transmission; managing HIV outbreaks among people who are homeless; improving viral suppression among people who use substances.

By Barbara Jungwirth and Myles Helfand

Overdoses and Smoking Are Taking the Lives of People With HIV Who Have Been Cured of Hepatitis C

"Providing HCV treatment alone while neglecting to concurrently address the social determinants of health will do little to improve the health outcomes of the majority of individuals with chronic HCV," the study authors wrote.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange

The Opioid Epidemic Is Fueling HIV Cluster Outbreaks -- Here's How the CDC is Responding

Epidemiologists are using a combination of molecular surveillance and tuberculosis-style contact tracing in hopes of helping local health departments curb HIV transmissions.

By Sony Salzman

Many Providers Are Biased Against Prescribing PrEP to People Who Inject Drugs

Health care providers often believe stereotypes that PWID are irresponsible and won't adhere to PrEP, according to data presented at the 2019 National HIV Prevention Conference.

By Sony Salzman

Chemsex Doesn't Impact PrEP Adherence, New Study Finds

Although people living with HIV who "party and play" appear more likely to struggle with treatment adherence, new research suggests that concern does not apply to PrEP.

By Sony Salzman

'Drug Users Are People Too': Addressing Opioid Addiction, Chemsex, Alcoholism, and Smoking Among People Living With HIV

A CROI 2019 symposium demonstrated the need for continued research and programs that address substance use and its impact on people living with HIV.

By Sony Salzman

Drug Use May Be Increasing Syphilis Rates Among HIV-Positive Cisgender Women, Studies Show

The global increase in sexually transmitted infections was a major focus of the CROI 2019 meeting in Seattle, Washington.

By Kenyon Farrow

Gay Men, Substance Use, and Harm Reduction: It's Time to Act

"Placing more attention on meeting the sexual health and holistic wellness needs of gay men affected by sexualized substance use is critical," writes the associate director of Ontario's Gay Men's Sexual Health Alliance.

By Dane Griffiths for Canadian AIDS Treatment Information Exchange

Pharma Payments to Doctors Associated With Spike in Opioid Deaths, New Study Reveals

After years of anecdotes and speculation, harm reduction and pharma watchdog advocates have data to back claims that the spike in opioid deaths in the U.S. can be tied to pharmaceutical companies marketing highly addictive opioids to doctors.

By Kenyon Farrow

New Dangers Emerge as Cocaine, Meth, and Other Stimulants Overtake Opioids

Data presented at the National Cocaine, Meth, and Stimulant Summit highlighted the dangerous fusion of the opioid and stimulant epidemics, creating an opportunity for a significant increase in new cases of HIV and HCV.

By David Fawcett, Ph.D., L.C.S.W.